MedMira Inc (MMIRF)
0.06
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
MedMira Profit Margin (Quarterly): -397.3% for Jan. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -397.3% |
| October 31, 2023 | -662.1% |
| July 31, 2023 | -2.73K% |
| April 30, 2023 | -556.5% |
| January 31, 2023 | -287.6% |
| October 31, 2022 | -523.7% |
| July 31, 2022 | -360.3% |
| April 30, 2022 | -126.9% |
| January 31, 2022 | -157.4% |
| October 31, 2021 | -241.9% |
| July 31, 2021 | -577.3% |
| April 30, 2021 | -403.1% |
| January 31, 2021 | -119.7% |
| October 31, 2020 | 44.62% |
| July 31, 2020 | -41.67% |
| April 30, 2020 | -794.1% |
| January 31, 2020 | -646.6% |
| October 31, 2019 | -525.8% |
| July 31, 2019 | -453.0% |
| April 30, 2019 | -357.5% |
| January 31, 2019 | -458.0% |
| October 31, 2018 | -354.7% |
| July 31, 2018 | -270.8% |
| April 30, 2018 | -860.1% |
| January 31, 2018 | -388.2% |
| Date | Value |
|---|---|
| October 31, 2017 | -444.7% |
| July 31, 2017 | -374.6% |
| April 30, 2017 | -390.3% |
| January 31, 2017 | -283.9% |
| October 31, 2016 | -377.8% |
| July 31, 2016 | |
| April 30, 2016 | -527.0% |
| January 31, 2016 | -71.65% |
| October 31, 2015 | -55.80% |
| July 31, 2015 | -38.84% |
| April 30, 2015 | -63.33% |
| January 31, 2015 | -143.5% |
| October 31, 2014 | -200.0% |
| July 31, 2014 | -40.17% |
| April 30, 2014 | -190.7% |
| January 31, 2014 | -273.2% |
| October 31, 2013 | -177.5% |
| July 31, 2013 | -127.3% |
| April 30, 2013 | -262.7% |
| January 31, 2013 | |
| October 31, 2012 | 26.14% |
| July 31, 2012 | |
| April 30, 2012 | -850.0% |
| January 31, 2012 | -512.1% |
| October 31, 2011 | -814.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.73K%
Minimum
Jul 2023
44.62%
Maximum
Oct 2020
-503.4%
Average
-403.1%
Median
Apr 2021
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -72.32% |
| Gross Profit Margin (Quarterly) | 45.82% |
| Operating Margin (Quarterly) | -247.6% |
| Return on Net Operating Assets | -72.32% |